Loading
Latest filing published 22 Apr 2021 for GenMark Diagnostics, Inc., €2.9M.
Michael John Harkins is a declared insider of GenMark Diagnostics, Inc., with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 25 February 2020 to 22 April 2021.
Every open-market trade on record is a sale: 6 sales worth €342k. The rest of the record consists of 3 share grants and 1 option exercise. Since January 2021: no purchases and 3 sales on the market.
The record was last updated on 22 April 2021 with a transaction (€2.9M) in GenMark Diagnostics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations